Michael Andreeff
Michael Andreeff
Verified email at mdanderson.org
Cited by
Cited by
Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid)
RP Warrell Jr, SR Frankel, WH Miller Jr, DA Scheinberg, LM Itri, ...
New England Journal of Medicine 324 (20), 1385-1393, 1991
Early results of a chemoimmunotherapy regimen of fludarabine, cyclophosphamide, and rituximab as initial therapy for chronic lymphocytic leukemia
MJ Keating, S O’Brien, M Albitar, S Lerner, W Plunkett, F Giles, M Andreeff, ...
Journal of clinical oncology 23 (18), 4079-4088, 2005
Human bone marrow–derived mesenchymal stem cells in the treatment of gliomas
A Nakamizo, F Marini, T Amano, A Khan, M Studeny, J Gumin, J Chen, ...
Cancer research 65 (8), 3307-3318, 2005
Bone marrow-derived mesenchymal stem cells as vehicles for interferon-β delivery into tumors
M Studeny, FC Marini, RE Champlin, C Zompetta, IJ Fidler, M Andreeff
Cancer research 62 (13), 3603-3608, 2002
Flow cytometry in clinical cancer research
B Barlogie, MN Raber, J Schumann, TS Johnson, B Drewinko, ...
Cancer research 43 (9), 3982-3997, 1983
Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents
M Studeny, FC Marini, JL Dembinski, C Zompetta, M Cabreira-Hansen, ...
Journal of the National Cancer Institute 96 (21), 1593-1603, 2004
Mechanisms of apoptosis sensitivity and resistance to the BH3 mimetic ABT-737 in acute myeloid leukemia
M Konopleva, R Contractor, T Tsao, I Samudio, PP Ruvolo, S Kitada, ...
Cancer cell 10 (5), 375-388, 2006
Expression and prognostic significance of IAP-family genes in human cancers and myeloid leukemias
I Tamm, SM Kornblau, H Segall, S Krajewski, K Welsh, S Kitada, ...
Clinical Cancer Research 6 (5), 1796-1803, 2000
Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia
HM Kantarjian, S O’Brien, TL Smith, J Cortes, FJ Giles, M Beran, S Pierce, ...
Journal of Clinical Oncology 18 (3), 547-547, 2000
MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly …
R Garzon, S Liu, M Fabbri, Z Liu, CEA Heaphy, E Callegari, S Schwind, ...
Blood, The Journal of the American Society of Hematology 113 (25), 6411-6418, 2009
Mesenchymal stem cell transition to tumor-associated fibroblasts contributes to fibrovascular network expansion and tumor progression
EL Spaeth, JL Dembinski, AK Sasser, K Watson, A Klopp, B Hall, ...
PloS one 4 (4), e4992, 2009
Convention on nomenclature for DNA cytometry
W Hiddemann, J Schumann, M Andreeff, B Barlogie, CJ Herman, RC Leif, ...
Cytometry: The Journal of the International Society for Analytical Cytology …, 1984
MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia
R Garzon, S Volinia, CG Liu, C Fernandez-Cymering, T Palumbo, ...
Blood, The Journal of the American Society of Hematology 111 (6), 3183-3189, 2008
Treatment of Philadelphia chromosome–positive acute lymphocytic leukemia with hyper-CVAD and imatinib mesylate
DA Thomas, S Faderl, J Cortes, S O'Brien, FJ Giles, SM Kornblau, ...
Blood 103 (12), 4396-4407, 2004
Melphalan and purine analog–containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell …
S Giralt, PF Thall, I Khouri, X Wang, I Braunschweig, C Ippolitti, D Claxton, ...
Blood, The Journal of the American Society of Hematology 97 (3), 631-637, 2001
Cancer stem cell definitions and terminology: the devil is in the details
P Valent, D Bonnet, R De Maria, T Lapidot, M Copland, JV Melo, ...
Nature Reviews Cancer 12 (11), 767-775, 2012
Reverse phase protein array: validation of a novel proteomic technology and utility for analysis of primary leukemia specimens and hematopoietic stem cells
R Tibes, YH Qiu, Y Lu, B Hennessy, M Andreeff, GB Mills, SM Kornblau
Molecular cancer therapeutics 5 (10), 2512-2521, 2006
Direct evidence of mesenchymal stem cell tropism for tumor and wounding microenvironments using in vivo bioluminescent imaging
S Kidd, E Spaeth, JL Dembinski, M Dietrich, K Watson, A Klopp, ...
Stem cells 27 (10), 2614-2623, 2009
Inflammation and tumor microenvironments: defining the migratory itinerary of mesenchymal stem cells
E Spaeth, A Klopp, J Dembinski, M Andreeff, F Marini
Gene therapy 15 (10), 730-738, 2008
Concise review: dissecting a discrepancy in the literature: do mesenchymal stem cells support or suppress tumor growth?
AH Klopp, A Gupta, E Spaeth, M Andreeff, F Marini III
Stem cells 29 (1), 11-19, 2011
The system can't perform the operation now. Try again later.
Articles 1–20